aTyr Pharma, Inc. (ATYR) vs EUDA Health Holdings Limited (EUDA)
A side-by-side comparison of aTyr Pharma, Inc. and EUDA Health Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATYR
aTyr Pharma, Inc.
$0.29HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
EUDA
EUDA Health Holdings Limited
$17.30HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ATYR vs EUDA
growth of $100 · dividends reinvested · last 2yATYR -83.2% (-59.1%/yr)EUDA -65.8% (-41.5%/yr)EUDA compounded faster over this window
ATYR EUDA
ATYR vs EUDA: by the numbers
- •EUDA is the larger company ($32M vs $28M market cap).
- •Both run net losses; EUDA's is the smaller (-40.49% vs -32003.68% net margin).
- •Both shrank revenue over the past five years; EUDA's decline was smaller (-5.13% vs -38.74% CAGR).
Metrics side by side
Valuation
| Metric | ATYR | EUDA |
|---|---|---|
| Forward P/E | N/A | 10.81 |
| P/S ratio | 149.66 | 2.75 |
| P/B ratio | 0.58 | N/A |
Profitability
| Metric | ATYR | EUDA |
|---|---|---|
| Gross margin | -717.37% | 41.73% |
| Operating margin | -40856.32% | -36.42% |
| Net margin | -32003.68% | -40.49% |
| ROE | -124.64% | N/A |
| ROIC | -109.29% | N/A |
Growth (annualized)
| Metric | ATYR | EUDA |
|---|---|---|
| Revenue CAGR (5Y) | -38.74% | -5.13% |
Frequently asked
- Which has grown faster, ATYR or EUDA?
- Neither grew: over the past five years both shrank revenue, with EUDA's decline the smaller — ATYR at a -38.74% CAGR versus EUDA at -5.13%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.